Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1985-11-04
1987-09-29
Brown, J. R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
424 95, 530301, 530399, C07K 1512, A61K 3526, A61K 3724
Patent
active
046969152
ABSTRACT:
Parathymyosin alpha is a novel peptide isolated from mammalian thymus and contains approximately 105 amino acid residues. It bears a high degree of homology to prothymosin alpha both in sequence and amino acid composition. Parathymosin alpha acts as a blocker or modulator or prothymosin alpha activity.
REFERENCES:
patent: 4490289 (1984-12-01), Stern
Hackh's Chemical Dictionary, fourth ed., p. 326, "Homogeneity, Homogeneous".
IUPAC-IUB Joint Commission on Biochemical Nomenclature, 1983, pp. 11-37.
Goldstein et al., "Current Status of Thymosin . . . ", Recent Progress in Hormone Research, vol. 37, 1981, pp. 369-414.
Brown J. R.
Gould George M.
Hoffmann-La Roche Inc.
Prlina Julie M.
Saxe Jon S.
LandOfFree
Parathymosin alpha does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Parathymosin alpha, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Parathymosin alpha will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1589275